Publicaciones en colaboración con investigadores/as de Boston University (1)

2008

  1. Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: Results from the APEX study

    British Journal of Haematology, Vol. 143, Núm. 4, pp. 511-519